AMLo Biosciences raised €2.9M in a funding round in Apr 2022. The company is based in London, UK. Investors in the round: Ascension’s Life Fund, Conduit’s EIS Impact Fund, Esperante and 2 others. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
